The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.

Walsh, B W; Paul, S; Wild, R A; Dean, R A; Tracy, R P; Cox, D A; Anderson, P W

Walsh, B W; Paul, S; Wild, R A; Dean, R A; Tracy, R P; Cox, D A; Anderson, P W.

Affiliation

Walsh BW; Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. bwwalsh@bics.bwh.harvard.edu

J Clin Endocrinol Metab ; 85(1): 214-8, 2000 Jan.

Article in En | MEDLINE | ID: mdl-10634389

Subject(s)

C-Reactive Protein/metabolism; Estrogen Replacement Therapy; Homocysteine/blood; Raloxifene Hydrochloride/pharmacology; Aged; Double-Blind Method; Female; Fibrinogen/metabolism; Humans; Lipids/blood; Middle Aged; Postmenopause/metabolism; Prospective Studies; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Estrogen Replacement Therapy / Raloxifene Hydrochloride / Homocysteine Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links